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Currently, Swiss Medical Weekly boasts a highly interest-
ing and time-relevant contribution of Hug and colleagues,
titled “Medical end-of-life decisions in the oldest old in
Switzerland” which examines the differences between the
oldest old and younger patients in terms of the frequency
of various end-of-life decisions such as intensified allevia-
tion of pain and other symptoms and, most notably, with-
holding and withdrawing life-sustaining treatments [1].
This study is time-relevant as it is an inescapable truth that
we are being confronted with a rapidly ageing population
in many countries around the world. Already more than
half of all Swiss deaths concern people over the age of 80,
with a further increase expected in the future. These grow-
ing numbers of people also have increasingly long trajec-
tories of health decline – both physical and cognitive – and
of chronic and degenerative illness progression, depending
on their specific afflictions. Needless to say, this is putting
a high strain and pressure on the medical healthcare system
as well as on society and our communities to provide ad-
equate care for our oldest old. Not only is throwing more
professionals at the problem not a feasible solution, but al-
so the number of family caregivers available to every older
person with healthcare needs is set to dwindle in the near
future [2].
Older people living with serious illness and multiple old-
age related co-morbidities are thus regarded as a group in
a highly vulnerable position when it comes to their med-
ical care and decision making at the end of life. They are
largely unempowered and prone to medical paternalism
and ageism [3]. Likewise, their low functional status can
lead to clinician powerlessness and therapeutic pessimism
or nihilism [4]. As the authors assert: “The oldest old have
been reported to have less access to specialist or palliative
care, to receive adequate pain and symptom treatment less
often, and to be excluded from decision making more of-
ten” [1].
Though the authors did not specifically address end-of-life
care for the oldest old in Switzerland, they did find that
old age seems to be a determining factor for the preva-
lence of some types of end-of-life decisions, regardless of
cause of death, place of death, sex or marital status (all
of which differ substantially across age groups). The re-
searchers found a clear and consistent indication that life-
sustaining treatment attempts (artificial nutrition and hy-
dration, antibiotics, ventilator therapy, chemotherapy and
dialysis) are decided against more often among the oldest
old compared with younger age groups. Also, “the propor-
tions of patients for whom a specific treatment was taken
into consideration […] decreased with age for [most stud-
ied] types of treatment” [1].
Though this is not necessarily unequivocal evidence of old
age being a decisive factor in end-of-life decision mak-
ing, these findings are not very surprising as they match
with (albeit scarce) international findings and debate [3, 5].
Their real merit lies in our ability to reflect about poten-
tial explanations and the issues involved. It will often be
the case that in older people the cost-benefit analysis of at-
tempting life-sustaining treatment tips over to the negative
(perhaps even to the point that the treatment is not even
considered): the gained quantity of life does not lead to any
improvement in quality of life and/or does not weigh up to
the imposed burden for the patient. Often there will even
be no chance of any meaningful improvement in their situ-
ation. In those instances, there will indeed be an increased
aptitude and preparedness to discuss end of life (not neces-
sarily a “tacit” consensus that death is nearing, as the au-
thors suggest) [1].
Above all, the older person him/herself needs to have a say
in the matter, if not at the moment of decision making, then
at least beforehand via, for example, advance care plan-
ning conversations. This is the best way to avoid ageist rea-
soning in end-of-life decisions for the oldest old, that is,
attitudes that, all other things being equal, life (prolonga-
tion) in very old age is no longer as meaningful as it is in
younger patients [3, 6]. Furthermore, considerations relat-
ing to the difficulties of organising adequate care, to the
strain on the family or financial issues should be acknowl-
edged but cannot readily be admitted as reasons to for-
go life-sustaining treatment. As such, the age-old (no pun
intended) balancing act for physicians between therapeu-
tic tenacity on the one hand, and therapeutic nihilism and
ageism on the other hand is intensified in end-of-life deci-
sion making for the oldest old. This is what makes the old-
est old a fitting group for more focused research in the field
of end-of-life decision making.
One other thought relating to the age disparities found in
withholding treatment at the end of life: one could posit
that it is not so that physicians are not aggressive enough
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when it comes to the oldest old, but can to the contrary be
overly aggressive when it comes to younger people who
are dying. Within current debate on the medicalisation of
dying and on therapeutic tenacity [7], it is certainly a ques-
tion worth pondering.
The authors have used a highly robust and trustworthy
method, even though, as with any research, there are ob-
vious limitations. Although it is in itself of limited clinical
benefit, it is important to repeat this kind of population-
level research longitudinally to allow for analysis of evo-
lutions in end-of-life decision making as a monitoring and
reflection tool for practice and policy. However, the above
discussion shows us that large-scale surveys tell us only the
broad story, providing a helicopter view of differences, but
without the needed depth to definitively qualify or explain
them. As such, this research forms the basis and starting
point for further focused insights. For instance, examining
differences in end-of-life age disparities according to care
setting or region will allow us to (begin to) uncover the cul-
tural factors that are relevant in end-of-life decision mak-
ing in the oldest old, both in terms of medical culture and
in terms of public, patient and family attitudes, perceptions
and beliefs.
Also, as the authors concede [1], population-level research
does not convey many insights on the appropriateness or
the adequacy of end-of-life decision making, and the con-
siderations underlying end-of-life decisions. A next step is
to study the influencing factors and conditions in which
decisions are made in the oldest old, and to gauge dispar-
ities in the quality of that decision making, from the be-
ginning: who is involved?; to what extent and how are the
patient and family involved?; on what grounds are deci-
sions made?; to what extent do different clinical and ethi-
cal considerations come into play?
The study convincingly shows the need for more attention
on this age group when it comes to end-of-life issues. The
sheer number and proportion of deaths in old age (84%)
where explicit end-of-life decisions are made – and often
more than one single end-of-life decision [1] – is indica-
tive of the pervasiveness of the issue in medical practice.
Managing such situations well requires adequate training,
support and coping strategies. It is rarely a simple and
straightforward process, involving many practical, clinical
and ethical considerations and different actors, which is not
made easier if it concerns a very old person. As such, the
likely considerable burden for all those involved, as well
as the manner in which these decisions are made, deserves
all the attention it can get.
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